Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

Enoxaparin Shows Safety in Angioplasty – STEEPLE Study

12/09/2005

Gilles Montalescot The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the find

Gilles Montalescot


Gilles Montalescot

The STEEPLE trial randomised more than 3500 elective angioplasty patients to unfractionated heparin or either of two dose levels of enoxaparin. Gilles Montalescot presented the findings in Stockholm and talked about them with Audio Medica.
[audio:https://www.audiomedica.com/podcasting/15.Gilles_Montalescot-The_STEEPLE_trial_randomised_more_than_3500_elective_angioplasty_patients.mp3]

Click here for all the interviews from ESC 2005